Determination of azithromycin heteroresistant Campylobacter jejuni in traveler’s diarrhea

Abstract Campylobacter is the most common cause of traveler’s diarrhea (TD) and human bacterial gastroenteritis. A heteroresistant Campylobacter jejuni (C. jejuni) isolate, identified by microbiological methods and characterized with molecular techniques, was obtained from a traveler in Nepal suffer...

Full description

Bibliographic Details
Main Authors: Woradee Lurchachaiwong, Supaporn Ruksasiri, Patcharawalai Wassanarungroj, Oralak Serichantalergs, Ladaporn Bodhidatta, John Crawford, Sanjaya Kumar Shrestha, Prativa Pandey
Format: Article
Language:English
Published: BMC 2019-05-01
Series:Gut Pathogens
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13099-019-0301-1
Description
Summary:Abstract Campylobacter is the most common cause of traveler’s diarrhea (TD) and human bacterial gastroenteritis. A heteroresistant Campylobacter jejuni (C. jejuni) isolate, identified by microbiological methods and characterized with molecular techniques, was obtained from a traveler in Nepal suffering TD. The presence of atypical colonies within the clear zone of inhibition was the first evidence of an atypical phenotype, leading to additional characterization of this heteroresistant strain. Antimicrobial susceptibility testing (AST) and population analysis profiling (PAP) demonstrated heteroresistance to azithromycin (AZM), a first-line antibiotic treatment for Campylobacter infections. Molecular analysis indicated a point mutation occurred on the 23S rRNA gene at the A2075G transitions, and the number of mutated gene copies was proportional to AZM resistance. Heteroresistant C. jejuni subpopulations from acute TD are likely underestimated, which may lead to treatment failures, as was the case for this patient. The presence of a heteroresistant strain in a high antibiotic environment may select for additional drug resistance and enable distribution into hospital and local communities.
ISSN:1757-4749